Anavex Life Sciences
AVXL
#8575
Rank
C$0.34 B
Marketcap
C$3.67
Share price
1.57%
Change (1 day)
-71.24%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -C$65.86 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$73.38 Million a decrease over its 2023 earnings that were of -C$63.94 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$65.86 Million-10.25%
2024 -C$73.38 Million14.77%
2023 -C$63.94 Million-17.49%
2022 -C$77.49 Million22.96%
2021 -C$63.02 Million35.36%
2020 -C$46.56 Million12.65%
2019 -C$41.33 Million29.09%
2018 -C$32.02 Million36.33%
2017 -C$23.49 Million17.11%
2016 -C$20.06 Million20.91%
2015 -C$16.59 Million-6.29%
2014 -C$17.7 Million337.28%
2013 -C$4.05 Million
2008 -C$7.49 Million106.01%
2007 -C$3.64 Million8848.98%
2006 -C$0.05 Million-79.99%
2005 -C$0.21 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
C$0.23 B-449.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
C$10.31 M-115.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-C$6.83 Million-89.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
C$0.38 B-671.48%๐Ÿ‡บ๐Ÿ‡ธ USA